Point72 Asset Management, L.P. - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 300 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2017. The put-call ratio across all filers is 2.07 and the average weighting 0.2%.

Quarter-by-quarter ownership
Point72 Asset Management, L.P. ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q1 2018$7,960,000
+538.3%
500,000
+733.3%
0.03%
+560.0%
Q4 2017$1,247,000
-97.5%
60,000
-98.3%
0.01%
-97.8%
Q3 2017$50,155,000
+5698.3%
3,500,000
+6900.0%
0.22%
+4380.0%
Q2 2017$865,000
-78.2%
50,000
-86.1%
0.01%
-77.3%
Q1 2017$3,960,000
-79.3%
359,000
-72.8%
0.02%
-83.6%
Q4 2016$19,166,000
-87.1%
1,320,000
-78.2%
0.13%
-87.2%
Q3 2016$148,560,000
+40.1%
6,051,300
+14.9%
1.04%
+44.9%
Q2 2016$106,025,000
-1.8%
5,264,400
+28.3%
0.72%
-12.9%
Q1 2016$107,948,000
+5831.2%
4,104,500
+22830.2%
0.83%
+5420.0%
Q4 2015$1,820,000
-80.9%
17,900
-58.3%
0.02%
-77.3%
Q2 2015$9,530,000
-49.7%
42,900
-67.6%
0.07%
-50.4%
Q4 2014$18,933,000
-90.9%
132,300
-91.6%
0.13%
-91.5%
Q3 2014$207,309,000
+7.5%
1,580,100
+3.4%
1.56%
+26.2%
Q2 2014$192,788,0001,528,6061.24%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q3 2017
NameSharesValueWeighting ↓
Brave Warrior Advisors 5,701,010$1,266,479,00036.57%
Ruane, Cunniff & Goldfarb 33,884,050$7,527,342,00035.90%
LeVasseur Capital Partners LLC 188,804$41,943,00034.97%
Pershing Square Capital Management 19,473,933$4,326,134,00029.95%
FARLEY CAPITAL L.P. 141,020$31,328,00024.16%
Ratan Capital Management LP 1,038,033$230,599,00021.97%
Marble Arch Investments 1,069,000$237,478,00020.47%
Arrow Capital Management, LLC 144,461$32,092,00018.04%
Tesuji Partners 1,368,040$303,910,00017.93%
ValueAct Holdings 14,994,261$3,330,975,00017.54%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders